Yuvafem 10 MCG vaginal insert 18S
Ended Awarded
- Contract number
- SPE2DB25FXKFQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,187
Award facts
- Contract value 100% obligated
- $1,187.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Yuvafem 10 microgram vaginal inserts (18-count). This firm fixed-price delivery order, valued at $1,187.20, represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. This underlying IDC vehicle enables flexible ordering of medications and medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, has demonstrated extensive capability in meeting federal medical procurement requirements through its competitively awarded contracts with the Defense Logistics Agency. The company's federal contract portfolio encompasses a diverse range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies. The delivery order is scheduled for completion by August 28, 2025, reflecting the standard execution timeline for routine pharmaceutical supply orders under the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FXKFQ?
SPE2DB25FXKFQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FXKFQ worth?
The government has obligated $1,187 on SPE2DB25FXKFQ.
Is contract SPE2DB25FXKFQ an order under another contract?
Yes. SPE2DB25FXKFQ is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXKFQ competed?
The extent of competition for SPE2DB25FXKFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award